Etoricoxib and celecoxib sensitive indomethacin‐responsive headache disorders

Indomethacin‐responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches. Many patients show a rapid therapeutic response to indomethacin, which is limited by intolerability. Etoricoxib...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Headache 2022-03, Vol.62 (3), p.383-388
Hauptverfasser:	Farag, Mena, Bahra, Anish
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents, Non-Steroidal - pharmacology Case reports Celecoxib Celecoxib - adverse effects cyclo‐oxygenase‐2 inhibitors Disorders etoricoxib Etoricoxib - therapeutic use Headache Headache - chemically induced Headache - drug therapy Headache Disorders - drug therapy Humans Indomethacin Indomethacin - adverse effects indomethacin‐responsive headache disorders Oxygenase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!